Download the cv of Dr. Karel Decaestecker

CURRICULUM VITAE
Personal data
Decaestecker Karel
°16/02/1981, Ostend (Belgium)
Married to Margot Verkaemer and Father of Anna (°13/08/2008) and Martha (°05/07/2010)
Professional address:
Urologie 0P3 De Pintelaan 185
9000 Gent (België)
Tel.: 0032 9 3320131
Fax: 0032 9 3323889
[email protected]
www.uzgent.be
Education - Training
Secondary School
1993-1999: Koninklijk Atheneum Diksmuide ASO, Maths – Sciences, Result: 85,5%
Higher Education: Training in Medicine at the University of Ghent
1999-2006: resulting in the academic degree of Medical Doctor / Master in Medicine magna
cum laude 04/07/2006
Principles of electrocardiography (28/01/2003)
Principles of radiation physics and radiation protection (07/072006)
Post-Graduate Certification Emergency Medicine (31/01/2008)
Post-Graduate training Surgery/Urology
2006-2008: Training in General Surgery, OLV van Lourdes Ziekenhuis Waregem, Belgium
2008-2012: Training in Urology, UZGent, University Hospital Ghent, Belgium
2011: Fellowship laparoscopy and robot-assisted laparoscopy AZ Groeninghe Kortrijk and
OLV Ziekenhuis Aalst, Belgium
National Board certification specialisation as urologist 02/08/2012
Fellow of the European Board of Urology (FEBU) 02/07/2012
2011: second highest score FEBU written exam 2011 Prague; 2012: oral exam score 9/10
Ph.D. 2010-2015: Metastasis-directed therapy for oligometastatic prostate cancer recurrence,
successfully defended 11/09/2015, resulting in academic degree of Doctor of Medical Science
Current status
Member of staff at the Department of Urology, Ghent University Hospital
Subspecialisation Uro-oncology and robot-assisted surgery
Multidisciplinary oncological care for prostate, urothelial, kidney and testicular
cancer
Bladder cancer surgery (open and robot-assisted)
-Totally intracorporeal robot assisted radical cystectomy and urinary
diversion (ileal conduit, neobladder, pouch)
-Robot assisted partial cystectomy and bladder brachytherapy
Kidney cancer surgery:
-Open and robotic radical and partial nephrectomy
-Open radical nephrectomy with caval thrombectomy
Open and robot-assisted pelvic and retroperitoneal (salvage) lymphadenectomy
(prostate cancer, testicular cancer, urothelial cancer)
Multidisciplinary approach for abdominal and pelvic cancers in collaboration
with gynaecology, gastro-intestinal and vascular surgery.
Special interest in Robotic Kidney Transplantation program in Belgium together with
thoraco-vascular surgery: first robotic kidney transplantation in Belgium 16/3/2016.
Member of the UOGG (Uro-Oncology Group Ghent)
Member of the EUOG (European Uro-Oncology Group)
Member of the EAU (European Association of Urology)
Member of the ERUS (EAU Robotic Urology Section) Scientific Working Group
Member of the YAU (Young Academic Urologists) Expert Group, Urothelial cancer section
Member of the European Group of Robotic Kidney Transplantation
Member of the BVU (Belgische Vereniging voor Urologie)
Member of the Working Group Quality of Care of the BAU (Belgian association of Urology)
Scientific Research - Publications
A1 publications:
- Collins J, Hosseini A, Adding C, Nyberg T, Koupparis A, Rowe E, Perry M, Issa R,
Schumacher M, Wijburg C, Canda AE, Balbay MD, Decaestecker K, Schwentner C, Stenzl
A, Edeling S, Pokupić S, D'Hondt F, Mottrie A, Wiklund P. Early recurrence patterns
following totally intracorporeal Robotic-assisted Radical Cystectomy: Results from the EAU
Robotic Urology Section (ERUS) Scientific Working Group. Eur Urol. 2016 accepted
October 17.
- De Visschere P, Lumen N, Ost P, Decaestecker K, Pattyn E, Villeirs G. Dynamic contrastenhanced imaging has limited added value over T2-weighted imaging and diffusionweighted imaging when using PI-RADSv2 for diagnosis of clinically significant prostate
cancer in patients with elevated PSA. Clin Radiol. 2016 Oct 7.
http://dx.doi.org/10.1016/j.crad.2016.09.011
- Van Hemelryk A, De Meerleer G, Ost P, Poelaert F, De Gersem G, Decaestecker K, De
Visschere P, Fonteyne V. The outcome for pathological node positive prostate cancer
patients treated with intensity-modulated radiotherapy and androgen deprivation therapy: a
case-matched analysis of pN1 and pN0 patients. Int J Radiat Oncol Biol Phys. 2016 Oct
1;96(2):323-32. http://dx.doi.org/10.1016/j.ijrobp.2016.06.011
- Lumen N, Poelaert F, Oosterlinck W, Lambert E, Decaestecker K, Tailly T, Hoebeke P,
Spinoit AF. Non-transecting anastomotic repair in urethral reconstruction: surgical and
functional outcome. J Urol. 2016 Jun 12. http://dx.doi.org/10.1016/j.juro.2016.06.016
- Collins J, Patel H, Adding C, Annerstedt M, Dasgupta P, Khan S, Artibani W, Gaston R,
Piechaud T, Catto J, Koupparis A, Rowe E, Perry M, Issa R, McGrath J, Kelly J,
Schumacher M, Wijburg C, Canda AE, Balbay MD, Decaestecker K, Schwentner C, Stenzl
A, Edeling S, Pokupić S, Stockle M, Siemer S, Sanchez-Salas R, Cathelineau X, Weston R,
Johnson M, D'Hondt F, Mottrie A, Hosseini A, Wiklund P. Enhanced Recovery After
Robot-assisted Radical Cystectomy: EAU Robotic Urology Section Scientific Working
Group Consensus View. Eur Urol. 2016 May 24. Review.
http://dx.doi.org/10.1016/j.eururo.2016.05.020
- Decaestecker K, Oosterlinck W. Managing the adverse events of intravesical Bacillus
Calmette-Guérin therapy. Research and Reports in Urology 2015; Oct 23;7:157-63. Review.
http://dx.doi.org/10.2147/RRU.S63448
- Decaestecker K, Lumen N, Spinoit AF, Everaert K, Fiers T, Oosterlinck W. Varicocoele:
the origin of benign prostatic hyperthrophy? Testosteron dosages in the periprostatic plexus.
Acta Clin Belg. 2016 Jun 9:1-3.
- Vermassen T, Van Praet C, Poelaert F, Lumen N, Decaestecker K, Hoebeke P, Van Belle S,
Rottey S, Delanghe J. Diagnostic accuracy of urinary prostate protein glycosylation profiling
in prostatitis diagnosis. Biochemia Medica 2015; Oct 15;25(3):439-49.
http://dx.doi.org/10.11613/BM.2015.045
- Beysens M, Palminteri E, Oosterlinck W, Spinoit AF, Hoebeke P, François P, Decaestecker
K, Lumen N. Anastomotic Repair versus Free Graft Urethroplasty for Bulbar Strictures: A
Focus on the Impact on Sexual Function. Adv Urol. 2015;912438.
http://dx.doi.org/10.1155/2015/912438.
- Devos J, Van Praet C, Decaestecker K, Claeys T, Fonteyne V, Decalf V, De Meerleer G,
Ost P, Lumen N. Cognitive factors influencing treatment decision-making in patients with
localised prostate cancer: development of a standardised questionnaire. Acta Clinica Belgica
2015; Mar 27. http://dx.doi.org/10.1179/2295333715Y.0000000015.
- Decaestecker K, Lumen N, Ringoir A, Oosterlinck W. Ablative Intravesical Chemotherapy
for Small Recurrent Non-Muscle-Invasive Bladder Cancer: A Prospective Study. Urologia
Internationalis 2015; Mar 14. http://dx.doi.org/10.1159/000377639.
- Lumen N, Beysens M, Van Praet C, Decaestecker K, Spinoit AF, Hoebeke P, Oosterlinck
W. Perineal urethrostomy: surgical and functional evaluation of two techniques. Biomed
Research International 2015; 2015:365715. http://dx.doi.org/10.1155/2015/365715.
- Claeys T, Van Praet C, Lumen N, Ost P, Fonteyne V, De Meerleer G, Lambert B, Delrue L,
De Visschere P, Villeirs G & Decaestecker K. Salvage pelvic lymph node dissection in
recurrent prostate cancer : surgical and early oncological outcome. Biomed Research
International 2015; 2015:198543. http://dx.doi.org/10.1155/2015/198543.
- Oosterlinck W & Decaestecker K. The correct sequence of intravesical chemotherapy and
Bacillus Calmette-Guérin for non-muscle-invasive bladder cancer. European Urology 2015;
67(3):517-8. http://dx.doi.org/10.1016/j.eururo.2014.11.028.
- Decaestecker K & Oosterlinck W. Transurethral resection of the prostate in recurrent acute
bacterial prostatitis. Urologia Internationalis 2015; 94(4):442-4.
http://dx.doi.org/10.1159/000367667.
- Vermassen T, Van Praet C, Lumen N, Decaestecker K, Vanderschaeghe D, Callewaert N,
Villeirs G, Hoebeke P, Van Belle S, Rottey S & Delanghe J. Urinary prostate protein
glycosylation profiling as a diagnostic biomarker for prostate cancer. Prostate 2015;
75(3):314-322. http://dx.doi.org/10.1002/pros.22918.
- Ost P, Bossi A, Decaestecker K, De Meerleer G, Giannarini G, Karnes RJ, Roach M &
Briganti A. Metastasis-directed therapy of regional and distant recurrences after curative
treatment of prostate cancer : a systematic review of the literature. European Urology2015;
67(5): 852-863. http://dx.doi.org/10.1016/j.eururo.2014.09.004.
- Fonteyne V, Ost P, Vanpachtebeke F, Colman R, Sadeghi S, Villeirs G, Decaestecker K &
De Meerleer G. Rectal toxicity after intensity modulated radiotherapy for prostate cancer :
which rectal dose volume constraints should we use? Radiotherapy and Oncology 2014;
113(3):398-403. http://dx.doi.org/10.1016/j.radonc.2014.10.014.
- Decaestecker K, De Meerleer G, Ameye F, Fonteyne V, Lambert B, Joniau S, Delrue L,
Billiet I, Duthoy W, Junius S, Huysse W, Lumen N & Ost P. Surveillance or metastasisdirected Therapy for OligoMetastatic Prostate cancer recurrence (STOMP) : study protocol
for a randomized phase II trial. BMC Cancer 2014; 14(1):671.
http://dx.doi.org/10.1186/1471-2407-14-671.
- Van Praet C, Decaestecker K, Fonteyne V, Ost P, De Visschere P, Verschuere S, Rottey S
& Lumen N. Contemporary minimally-invasive extended pelvic lymph node dissection for
prostate cancer before curative radiotherapy : prospective standardized analysis of
complications. International Journal of Urology 2014; 21(11):1138-43.
http://dx.doi.org/10.1111/iju.12534.
- Decaestecker K, De Meerleer G, Lambert B, Delrue L, Fonteyne V, Claeys T, De Vos F,
Huysse W, Hautekiet A, Maes G & Ost P. Repeated stereotactic body radiotherapy for
oligometastatic prostate cancer recurrence. Radiation Oncology 2014; 9(1):135.
http://dx.doi.org/10.1186/1748-717X-9-135.
- Ost P, Decaestecker K, Lambert B, Fonteyne V, Delrue L, Lumen N, Ameye F & De
Meerleer G. Prognostic factors influencing prostate cancer-specific survival in non-castrate
patients with metastatic prostate cancer. The Prostate 2014; 74(3):297-305.
http://dx.doi.org/10.1002/pros.22750.
- Van Praet C, Libbrecht L, D'Hont F, Decaestecker K, Fonteyne V, Verschuere S, Rottey S,
Praet M, De Visschere P & Lumen N. Agreement of Gleason score on prostate biopsy and
radical prostatectomy specimen : is there improvement with increased number of biopsy
cylinders and the 2005 revised Gleason scoring? Clinical Genitourinary Cancer 2014;
12(3):160-166. http://dx.doi.org/10.1016/j.clgc.2013.11.008.
- Van Praet C, Ost P, Lumen N, De Meerleer G, Vandecasteele K, Villeirs G, Decaestecker
K & Fonteyne V. Postoperative high-dose pelvic radiotherapy for N+ prostate cancer :
toxicity and matched case comparison with postoperative prostate bed-only radiotherapy.
Radiotherapy and Oncology 2013; 109(2): 222-228.
http://dx.doi.org/10.1016/j.radonc.2013.08.021.
- Fonteyne V, Lumen N, Ost P, Van Praet C, Vandecasteele K, De Gersem W, Villeirs G, De
Neve W, Decaestecker K, De Meerleer G. Hypofractionated intensity-modulated arc
therapy for lymph node metastasized prostate cancer: toxicity and 3-years clinical outcome.
Radiotherapy and Oncology 2013; 109(2):229-234.
http://dx.doi.org/10.1016/j.radonc.2013.08.006.
- Lumen N, Van Praet C, De Troyer B, Fonteyne V, Oosterlinck W, Decaestecker K &
Mottrie A. Safe introduction of robot-assisted radical prostatectomy after a training program
in a high-volume robotic centre. Urologia Internationalis 2013; 91(2):145-152.
http://dx.doi.org/10.1159/000350652.
- Berkovic P, De Meerleer G, Delrue L, Lambert B, Fonteyne V, Lumen N, Decaestecker K,
Villeirs G, Vuye P, Ost P. Salvage stereotactic body radiotherapy for patients with limited
prostate cancer metastases: deferring androgen deprivation therapy. Clinical Genitourinary
Cancer 2013; 11(1):27-32. http://dx.doi.org/10.1016/j.clgc.2012.08.003.
- Oosterlinck W & Decaestecker K. Current strategies in the treatment of non-muscleinvasive bladder cancer. Expert Review of Anticancer Therapy 2012; 12(8):1097-1106.
http://dx.doi.org/10.1586/ERA.12.87.
- Hoebeke P, Decaestecker K, Beysens M, Opdenakker Y, Lumen N, Monstrey S. Erectile
Implants in Female-to-Male Transsexuals: Our Experience in 129 Patients. European
Urolology 2010; 57(2):334-341. http://dx.doi.org/10.1016/j.eururo.2009.03.013.
- Hoebeke P, De Pooter J, Decaestecker K, Raes A, Dehoorne J, Van Laecke E, Vandewalle
J. Solifenacin for therapy resistant overactive bladder. Journal of Urology 2009;
182(4Suppl):2040-4. http://dx.doi.org/10.1016/j.juro.2009.05.100.
- Lumen N, Oosterlinck W, Decaestecker K, Monstrey S, Hoebeke P. Endoscopic incision of
short (<3 cm) urethral strictures after phallic reconstruction. Journal of Endourology 2009;
23(8): 1329-32. http://dx.doi.org/10.1089/end.2008.0666.
- Weyers S, Decaestecker K, Verstraelen H, Monstrey S, T’Sjoen G, Gerris J, Hoebeke P,
Villeirs G. Clinical and transvaginal sonographic evaluation of the prostate in transsexual
women. Urology 2009; 74(1):191-6. http://dx.doi.org/10.1016/j.urology.2008.06.016.
- Decaestecker K, Philibert P, De Baere E, Hoebeke P, Kaufman JM, Sultan C, T’Sjoen G. A
novel mutation c.118delA in exon 1 of the androgen receptor gene resulting in complete
androgen insensitivity syndrome within a large family. Fertility and sterility 2008;
89(5):1260.e3-7. http://dx.doi.org/10.1016/j.fertnstert.2007.04.057.
- Hoebeke P, Decaestecker K, Vandewalle J, Dehoorne J, Raes A, Verleyen P, Van Laecke
E. The effect of botulinum-A toxin in incontinent children with therapy resistant overactive
detrusor. Journal of Urology 2006; 176(1):328-30. http://dx.doi.org/10.1016/S00225347(06)000301-6.
- Hoebeke P, Selvaggi G, Ceulemans P, De Cuypere G, T’Sjoen G, Weyers S, Decaestecker
K, Monstrey S. Impact of sex reassignment surgery on lower urinary tract function.
European Urology 2004; 47(3):398-402. http://dx.doi.org/10.1016/j.eururo.2004.10.008.
A2 publications
- Decaestecker K & Oosterlinck W. Ernstige verwikkelingen van intravesicaal gebruik van
Bacillus Calmette-Guérin. Tijdschrift voor Geneeskunde 2016; 72(19):1108-1110.
- Dekeyzer S, Peters N, Smeets P, De Visschere P, Decaestecker K & Gosselin R.
Lymphangioleiomyomatosis presenting with perirenal hemorrhage. Journal Belge de
Radiologie – Belgisch Tijdschrift voor Radiologie. 2015.
- Beysens M, Lapauw B, Gykiere P, Dekeyzer S, Lumen N & Decaestecker K. Minimally
invasive approach of bladder paraganglioma : case report and review of literature. Austin
Journal of Clinical Case Reports 2014; 1(7):1034.
https://biblio.ugent.be/publication/5856195.
- De Visschere P, Oosterlinck W, De Meerleer G, Decaestecker K, Fonteyne V, Lumen N,
Ost P & Villeirs G. Multiparametrische prostaat-MRI : klinische toepassingen. Tijdschrift
voor Geneeskunde 2014; 70(7):369-376. https://biblio.ugent.be/publication/4419725.
- Decaestecker K & Tummers P. Oncologische heelkunde bij hoogbejaarde patiënten met
urologische of gynaecologische tumoren. Tijdschrift voor Geneeskunde 2014; 70(17):930934. https://biblio.ugent.be/publication/5706548.
- Decaestecker K, De Meerleer G, Rottey S, Lumen N, Fonteyne V, Oosterlinck W.
Blaasconserverende behandelingen voor invasieve blaaskanker: een te weinig gebruikte
mogelijkheid. Tijdschrift Voor Geneeskunde 2012; 68(6):190-194.
https://biblio.ugent.be/publication/3178525.
- Oosterlinck W, Decaestecker K. Diagnosis, Treatment and follow-up of Low-grade Ta
Papillary Urothelial Bladder Neoplasms. European Urological Review 2011; 6(2):107-9.
https://biblio.ugent.be/publication/4100374.
- Lumen N, Hoebeke P, Deschepper E, Van Laecke E, Decaestcker K, Oosterlinck W.
Urethroplasty for failed hypospadias repair: a match-cohort analysis. Journal of Pediatric
Urology 2011; 7(2):170-3. http://dx.doi.org/10.1016/j.jpurol.2010.04.013.
- Decaestecker K, Van Daele P, Haeck L. Dumbbell tumor van de thoracale wervelzuil.
Tijdschrift voor Geneeskunde 2009; 65:630-632.https://biblio.ugent.be/publication/3178522.
- Decaestecker K, Keymeulen L, Moerloose K, Joos G. Roken en astma. Tijdschrift voor
Geneeskunde 2004; 60(14):1013-1021. https://biblio.ugent.be/publication/3178521.
A3-4 publications
- Decaestecker K. Cytoreductieve nefrectomie en metastasectomie bij gemetastaseerd
niercelcarcinoom. Andrologic 2013; 9(5):18-21. https://biblio.ugent.be/publication/5673726.
- Oosterlinck W & Decaestecker K. Open heelkunde voor niercelcarcinoom : wanneer en
hoe? Andrologic 2013; 9(4):26-29. https://biblio.ugent.be/publication/5673727.
Abstracts
- Collins J, Patel H, Adding C, Annerstedt M, Dasgupta P, Khan S, Artibani W, Gaston R,
Piechaud T, Catto J, Koupparis A, Rowe E, Perry M, Issa R, McGrath J, Kelly J,
Schumacher M, Wijburg C, Canda AE, Balbay MD, Decaestecker K, Schwentner C, Stenzl
A, Edeling S, Pokupić S, Stockle M, Siemer S, Sanchez-Salas R, Cathelineau X, Weston R,
Johnson M, D'Hondt F, Mottrie A, Hosseini A, Wiklund P. Enhanced recovery after robotassisted radical cystectomy: EAU Robotic Urology Section (ERUS) scientific working
group consensus statement view. In 13th Meeting of the EAU Robotic Urology Section
(ERUS 2015), Milan, Italy, 2016-09-14. Eur Urol Suppl 2016; 15(7):225
- Hosseini A, Collins J, Adding C, Nyberg T, Koupparis A, Perry M, Issa R , Rowe E,
Schumacher M, Wijburg C, Canda A, Balbay D, Decaestecker K, Schwentner C, Stenzl A,
Edeling S, Pokupić S, D’Hondt F, Mottrie A, Wiklund P. Oncological outcomes of totally
intracorporeal robot-assisted radical cystectomy: Results from the European Association of
Urology Robotic Urology Section (ERUS) scientific working group. In 13th Meeting of the
EAU Robotic Urology Section (ERUS 2015), Milan, Italy, 2016-09-14Eur Urol Suppl 2016;
15(7):232.
- Collins J, Hosseini A, Adding C, Nyberg T, Koupparis A, Rowe E, Perry M, Issa R,
Schumacher M, Wijburg C, Guru K, Canda A, Balbay D, Decaestecker K, Schwentner C,
Stenzl A, Edeling S, Pokupic S, Mottrie A, Wiklund P. Early recurrence patterns following
totally intracorporeal robotic-assisted radical cystectomy: Updates from the European
Association of Urology Robotic Urology Section (ERUS) scientific working group. In 13th
Meeting of the EAU Robotic Urology Section (ERUS 2015), Milan, Italy, 2016-09-14Eur
Urol Suppl 2016; 15(7):231.
- Decaestecker K, Vandamme E, Vanmarsnille T, Poelaert F. Neobladder versus ileal conduit
in Robot-Assisted Radical Cystectomy (RARC): Results from a high-volume academic
centre. In 13th Meeting of the EAU Robotic Urology Section (ERUS 2015), Milan, Italy,
2016-09-14Eur Urol Suppl 2016; 15(7):227-228.
- Poelaert F, Fonteyne V, Claeys T, Ost P, Decaestecker K, De Meerleer G, D'Hondt B, De
Visschere P, Lumen N. Whole pelvis intensity-modulated arc therapy for lymph node
metastasized prostate cancer: Oncologic outcomes and prognostic factors. In: EAU annual
meeting, Munich, Germany, 11-03-2016. European Urology Supplements 03/2016; 15(3):
e680. http://dx.doi.org/10.1016/S1569-9056(16)60682-6
- Collins J, Hosseini A, Adding C, Nyberg T, Koupparis A, Rowe E, Perry M, Issa R,
Schumacher M, Wijburg C, Guru K, Canda A, Balbay D, Decaestecker K, Schwentner C,
Stenzl A, Edeling S, Pokupic S, Mottrie A, Wiklund P. What is the evidence for unusual
recurrence patterns following totally intracorporeal robotic-assisted radical cystectomy?
Results from the EAU Robotic Urology Section (ERUS) Scientific Working Group. In:
EAU annual meeting, Munich, Germany, 11-03-2016. European Urology Supplements
European Urology Supplements 03/2016; 15(3): e625 (e625a).
http://dx.doi.org/10.1016/S1569-9056(16)60627-9
- Decaestecker K, Vanmarsnille T, Poelaert F, Hosseini A. Robot-assisted radical cystectomy
versus open radical cystectomy: complication rates and perioperative results in a single
academic center. In BAU 2015, Antwerp, Belgium, 2015-12-04.
- Hosseini A, Collins J, Adding C, Nyberg T, Koupparis A, Rowe E, Schumacher M, Wijburg
C, Canda A, Balbay D, Decaestecker K, Schwentner C, Stenzl A, Edeling S, Pokupić S,
Perry M, Issa R, Guru K, Mottrie A, Wiklund P. Oncological outcomes of totally
intracorporeal robot-assisted radical Cystectomy with a minimum of 3 years follow-up:
Results from the ERUS scientific working group. In 12th Meeting of the EAU Robotic
Urology Section (ERUS 2015), Bilbao, Spain, 2015-09-15. European Urology Supplements
09/2015; 14(5):98.
http://dx.doi.org/10.1016/S1569-9056(15)30202-5.
- Collins J, Hosseini A, Adding C, Nyberg T, Koupparis A, Rowe E, Perry M, Issa R,
Schumacher M, Wijburg C, Guru K, Canda A, Balbay D, Decaestecker K, Schwentner C,
Stenzl A, Edeling S, Pokupic S, Mottrie A, Wiklund P. Early recurrence patterns following
totally intracorporeal Robotic-assisted Radical Cystectomy. Results from the ERUS
Scientific Working Group. In 12th Meeting of the EAU Robotic Urology Section (ERUS
2015), Bilbao, Spain, 2015-09-15. European Urology Supplements 09/2015; 14(5):100.
http://dx.doi.org/10.1016/S1569-9056(15)30202-5.
- Hosseini A, Collins J, Koupparis A, Rowe E, Perry M, Issa R, Adding C, Nyberg T,
Schumacher M, Wijburg C, Canda A, Balbay D, Decaestecker K, Schwentner C, Stenzl A,
Edeling S, Pokupic S, Guru K, Mottrie A, Wiklund P. Complications after totally
intracorporeal robot-assisted radical cystectomy: Results from the ERUS scientific working
group. In 12th Meeting of the EAU Robotic Urology Section (ERUS 2015), Bilbao, Spain,
2015-09-15. European Urology Supplements 09/2015; 14(5):82.
http://dx.doi.org/10.1016/S1569-9056(15)30201-3.
- Collins J, Hosseini A, Schumacher M, Canda A, Wijburg C, Schwentner C, Stenzl A,
Balbay D, Decaestecker K, Edeling S, Pokupic S, Guru K, Mottrie A, Wiklund P. mp67-19
Oncological outcomes of totally intracorporeal robot-assisted radical cystectomy: results
from the erus scientific working group. In: AUA annual meeting, New Orleans, LA, USA,
15-05-2015. The Journal of Urology Supplements 2015; 193(4):e857.
http://dx.doi.org/10.1016/j.juro.2015.02.2502.
- Collins J, Hosseini A, Nyberg T, Schumacher M, Wijburg C, Canda A, Balbay D,
Decaestecker K, Schwentner C, Edeling S, Pokupić C, Mottrie A, Guru K, Wiklund P.
Complications after totally intracorporeal robot-assisted radical cystectomy: Results from
the ERUS scientific working group (ESWG). In: EAU annual meeting, Madrid, Spain 2003-2015. European Urology Supplements 03/2015; 14(2):e438.
http://dx.doi.org/10.1016/S1569-9056(15)60431-6.
- Collins, Hosseini A, Nyberg T, Schumacher M, Canda A, Wijburg C, Schwentner C, M.D.
Balbay M, Decaestecker K, Edeling S, Pokupić S, Mottrie A, Guru K, Wiklund P.
Oncological outcomes of totally intracorporeal robot-assisted radical cystectomy: Results
from the ERUS Scientific Working Group (ESWG). In: EAU annual meeting, Madrid, Spain
20-03-2015. European Urology Supplements 2015; 14(2):e540-e540b.
http://dx.doi.org/10.1016/S1569-9056(15)60533-4.
- Claeys T, Lumen N, Thuysbaert G, Praet M, De Meerleer G, Rottey S, Ost P, De Visschere
P, Villeirs G, Fonteyne V, Decaestecker K. Evaluation of the effect of cytoreductive
nephrectomy on the course of metastatic renal cell carcinoma: A single centre study. In:
EAU annual meeting, Madrid, Spain 20-03-2015. European Urology Supplements 2015;
14(2):728-728a. http://dx.doi.org/10.1016/S1569-9056(15)60720-5.
- Van Praet C, Poelaert F, Verschuere S, Libbrecht L, Praet M, Rottey S, Van Belle S,
Decaestecker K, Claeys T, Lumen N. : Chromosome X polysomy is associated with
increased androgen receptor expression in epithelial cells and reduced expression in stromal
cells in treatment-naive prostate cancer. In: 6th European Multidisciplinary Meeting on
Urological Cancers (EMUC), 2014-11-13, Lisbon, Portugal. European Urology
Supplements 2014; 13(5):104. http://dx.doi.org/10.1016/S1569-9056(14)61222-7.
- Claeys T, Van Praet C, Decaestecker K, Ost P, Fonteyne V, De Meerleer G, De Visschere
P, Villeirs G, Lumen N. Salvage pelvic lymph node dissection in prostate cancer: Surgical
and oncological outcome. In: 6th European Multidisciplinary Meeting on Urological
Cancers (EMUC), 2014-11-13, Lisbon, Portugal. European Urology Supplements 2014;
13(5):140-41. http://dx.doi.org/10.1016/S1569-9056(14)61308-7.
- Ost P, Huysse W, Delrue L, Decaestecker K, De Meerleer G, De Vos F, Fonteyne V, &
Lambert B. To prospectively compare F18-choline PET/CT and axial skeleton MRI for the
detection of bone metastases in patients with biochemically recurrent prostate cancer (PCa).
In: 6th European Multidisciplinary Meeting on Urological Cancers (EMUC) ; 3rd Meeting
of the EAU Section of Urological Imaging (ESUI), Lisbon, Portugal 2014-11-13. European
Urology Supplements 2014; 13(5):132-3.http://dx.doi.org/10.1016/S1569-9056(14)61287-2.
- Lambert B, Huysse W, Delrue L, De Man K, Goethals I, De Meerleer G, De Vos F,
Decaestecker K & Ost P. Comparison of fluor-18 choline PET/CT versus MRI for detecting
bone metastasis in relapsed prostate cancer. In: 2014 Annual congress of the European
Association of Nuclear Medicine (EANM 2014), Gothenburg, Sweden, 2014-10-18.
https://biblio.ugent.be/publication/4424194.
- Decaestecker K, Van Praet C & Lumen N. Robot-assisted salvage extended pelvic lymp
node dissection in prostate cancer. In: 11th Meeting of the EAU Robotic Urology Section
(ERUS 2014), Amsterdam, The Netherlands, 2014-09-17. 54. European Urology
Supplements 2014; 13(3):54. http://dx.doi.org/10.1016/S1569-9056(14)50135-2.
- Spinoit AF, Decaestecker K, Bamelis B, Groen LA, Van Laecke E, Claeys T & Hoebeke P.
Daytime incontinence as unusual presentation of transitional cell carcinoma of the bladder in
a 14 years-old girl : case report. In: ICCS Annual meeting 2014, Cairns, QLD, Australia,
2014-09-10. Australian and New Zealand continence journal 2014; 20(3):108-109.
- Decaestecker K, Lumen N. Neoadjuvant intravesical chemotherapy for small non-muscle
invasive bladder tumours. In EAU annual meeting, 2014-04-11, Stockholm, Sweden.
European Urology Supplements 2014; 13(1):e1106. http://dx.doi.org/10.1016/S15699056(14)61086-1.
- De Meerleer G, Claeys T, Delrue L, Lambert B, Lumen N, Fonteyne V, Decaestecker K,
Ost P. Should oligometastatic disease in prostate cancer be treated systemically?: the
radiation oncologist point of view. In: ESTRO forum, 2014-04-08, Vienna, Austria.
Radiotherapy and Oncology 2014; 111:6.http://dx.doi.org/10.1016/S0167-8140(15)30126-2.
- Ost P, Decaestecker K, Lambert B, Fonteyne V, Delrue L, Lumen N, De Meerleer G. The
importance of the number of metastases on prostate cancer-specific survival in patients with
noncastrate metastatic prostate cancer following curative treatment. In: 5th European
multidisciplinary meeting on Urological Cancers (EMUC), Marseille, France, 2013-11-15.
European Urology Supplements 2013; 12(6):167. http://dx.doi.org/10.1016/S15699056(13)62422-7.
- Decaestecker K, De Meerleer G, Delrue L, Lambert B, Fonteyne V, Lumen N, Van Praet C,
Berkovic P, Villeirs G, De Visschere P, Vuye P & Ost P. Metastasis-directed therapy for
oligmetastic prostate recurrence. In: 5th European multidisciplinary meeting on Urological
Cancers (EMUC 2013), Marseille, France, 2013-11-15. European Urology Supplements
2013; 12(6):176. http://dx.doi.org/10.1016/S1569-9056(13)62441-0. AWARD: second best
poster prize with oral presentation on EMUC 2013.
- Fonteyne V, Lumen N, Van Praet C, Ost P, Decaestecker K, De Meerleer G. High-dose
intensity-modulated arc radiotherapy for lymph node metastasized prostate cancer: Toxicity
and early clinical outcome. In: 5th European multidisciplinary meeting on Urological
Cancers (EMUC 2013), Marseille, France, 2013-11-15. European Urology Supplements
2013; 12(6):e191. http://dx.doi.org/10.1016/S1569-9056(13)60679-X.
- Van Praet C, Lumen N, De Meerleer G, Ost P, Vandecasteele K, Villeirs G, Decaestecker
K & Fonteyne V. Acute and late toxicity after postoperative high-dose pelvic radiotherapy
and androgen deprivation for node positive prostate cancer patients : a powerful tool that
should be handled with care?. In: Global congress on Prostate Cancer, Marseille, France,
2013-06-12.
- Van Praet C, Decaestecker K, Hoebeke P & Lumen N. Correlation between prostate
volume measured by transrectal and suprapubic ultrasound : can we do without TRUS? In:
Global congress on Prostate Cancer, Marseille, France, 2013-06-12.
- Van Praet C, Decaestecker K, Fonteyne V & Lumen N. Increased number of high-risk
factors following radical prostatectomy is associated with decreased biochemical recurrencefree survival in high-risk prostate cancer. In: Global congress on Prostate Cancer, Marseille,
France, 2013-06-12.
- Berkovic P, De Meerleer G, Delrue L, Lambert B, Fonteyne V, Lumen N, Decaestecker K,
Villeirs G, Vuye P, Ost P. Salvage stereotactic body radiotherapy for patients with limited
prostate cancer metastases: Deferring androgen deprivation therapy. In: 4th European
multidisciplinary meeting on Urological Cancers (EMUC 2012), Barcelona, Spain, 2012-1116. European Urology Supplements 2012; 11(5):189. http://dx.doi.org/10.1016/S15699056(13)60381-4.
- Van Praet C, Maes H, Fonteyne V, Decaestecker K, Villeirs G, Ost P, De Meerleer G &
Lumen N. Limited versus extended pelvic lymph node dissection in prostate cancer patients.
In: Global Congress on Prostate Cancer, Brussels, Belgium, 2012-06-28.
- Van Praet C, Lumen N, De Troyer B, Fonteyne V, Decaestecker K, De Meerleer G,
Oosterlinck W, Ost P & Mottrie A. Surgical outcome of robot-assisted radical prostatectomy
after a training program in a high-volume robotic centre. In: Global congress on Prostate
Cancer, Brussels, Belgium, 2012-06-28.
Awards
-
2011: second highest score FEBU written exam 2011 Prague: Sponsored USANZ
Trainee Week: Sydney, Australia.
Pfizer educational grant 2012
Astellas research award 2012
EMUC 2013: second best poster prize (oral presentation): Metastasis-directed therapy
for oligometastatic prostate cancer recurrence.
Participation in courses and congresses
-BAU 2008,
2009, 2010, 2011, 2012, 2013, 2014, 2015
-Elautprijs 2009, 2010, 2012, 2013, 2014, 2015, 2016
-EMUC European Multidisciplinary Meeting on Urological Cancers —Embracing Excellence
in Prostate, Bladder and Kidney Cancer 2009, 2012, 2013, 2014, 2015
-EAU 2012, 2014, 2015, 2016
-ERUS 2012, 2013, 2014, 2015, 2016
-ESRU.be 2010, 2011, 2012, 2013
-ESOU 2014
-ESU course (EAU 2012 Paris):
- Diagnosis and management of NMIBC
- Management and outcome of invasive and locally advanced bladder cancer
- Laparoscopic and robot-assisted laparoscopic radical cystectomy
- Radical cystectomy and orthotropic bladder substitution
-ESU Medical Oncology Course Genitourinary Cancer (MOGUC), Marseille 2013
-1st International Symposium on Hormonal Treatment of Prostate Cancer (Athens) 2009
-ESTRO course: Multidisciplinary Teaching course on Prostate Cancer (Firenze) 2010
-11th International training course on invasive bladder cancer and urinary diversion
(Mansoura-Egypt) 2010
-5th Uro starters package (Laparoscopy-Robot Training course) 2010
-Module 1: Endogent - Gent
-Module 2: Robot - Aalst
-Module 3: Laparoscopy/Robot - Strasbourg
-ERUS Master class on Partial Nephrectomy (Aalst) 2011
-9th European Urology Residents Education Programme (EUREP Prague) 2011
-USANZ Trainee Week (Sydney): on invitation 2011
-Advanced EUREP HOT Laparoscopic Training (Hamburg) 2012
Language competence
- mother tongue: Dutch
- other languages:
- English: advanced
- French: medium
Socio-cultural interests
*6 weeks of developmental cooperation in Africa (Kenia, Kwale district 2003):
Evaluation of prevention strategies of HIV and Plasmodium species transmission.
*3 months of developmental cooperation in Cambodia, january-march 2006: Inventory
of the surgical oncological pathology in two university hospital settings in comparison with a
provincial hospital in Cambodia - University of Phnom Penh